Key result
High-throughput functional mapping identifies ~1,800 pathogenic KCNQ1 variants linked to increased arrhythmia risk.
Why the study?
Functional characterization of numerous KCNQ1 variants of uncertain significance is essential to define their role in long QT syndrome and improve clinical interpretation and risk stratification.
What are the functional and clinical impacts of KCNQ1 variants on QT prolongation and arrhythmia risk?
Observational
What are the functional and clinical impacts of KCNQ1 variants on QT prolongation and arrhythmia risk?
A comprehensive functional atlas of KCNQ1 variants resolves numerous variants of uncertain significance and identifies dominant-negative effects as markers for higher arrhythmia risk.
May aid KCNQ1 variant reclassification in LQTS; leaves open prospective validation before guiding arrhythmia risk assessment.
BACKGROUND: Variants in the ion channel gene KCNQ1 are the leading cause of congenital long QT syndrome (LQTS), a disorder characterized by QT prolongation and risk of fatal arrhythmias. The expanding use of genetic testing has led to the identification of numerous variants of uncertain significance, complicating clinical interpretation and risk stratification. Functional characterization of KCNQ1 variants is essential to define their role in long QT syndrome and advance precision medicine in cardiovascular care. METHODS: We generated a nearly comprehensive variant library of 13 403 protein-coding variants in KCNQ1 . Using 4 pooled assays followed by high-throughput sequencing, we characterized the variants’ effects on cell surface abundance and channel function in both the variant-only and heterozygous states. Case–control analyses and data from large-scale biobanks were used to assess the clinical impact of loss-of-function variants on QT prolongation and long QT syndrome. Heterozygous assay results were used to determine dominant-negative effects, which were also evaluated for association with arrhythmia risk. Protein structural clustering of distinct classes of deleterious variants was analyzed. RESULTS: Across the 4 assays, we generated 49 305 functional measurements of KCNQ1 variants. Of the 13 403 KCNQ1 studied variants, 1757 demonstrated strong pathogenic evidence, and 6660 showed moderate benign evidence. Loss-of-function variants were significantly associated with QT prolongation and long QT syndrome in case–control and biobank analyses. Deleterious variants clustered within distinct structural domains based on their functional classification. A majority of pathogenic variants exhibited dominant-negative effects; these variants were linked to a higher risk of arrhythmia diagnoses than were haploinsufficient variants. CONCLUSIONS: This comprehensive KCNQ1 functional atlas provides novel functional evidence for most KCNQ1 variants of uncertain significance. It also reveals mechanistic principles linking genetic variation to ion channel biology and arrhythmia susceptibility, advancing cardiovascular precision medicine.
No takes yet. Share an insight, caveat, or question.
Harvey et al. (2026) conducted an observational in Long QT syndrome (LQTS) and QT prolongation. KCNQ1 loss-of-function and dominant-negative variants vs. Benign variants or wild-type was evaluated on Variant effect on cell surface abundance, channel function, and association with QT prolongation and long QT syndrome. Functional characterization of 13,403 KCNQ1 variants identified 1,757 pathogenic variants, with loss-of-function and dominant-negative effects significantly increasing arrhythmia risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: